Internal Medicine, Infectious Disease · Mobile, AL
NPI
1114940509
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
101 Memorial Hospital Dr Ste 200
Mobile, AL, 36608
Phone (251) 414-5900
Groups this clinician bills Medicare through
Medicare paid, 2024
$148K
76,530 services
Medicare patients, 2024
451
Average age 72
Drug cost, 2024
$1.3M
2,528 prescriptions
Company payments, 2025
$922
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward A Hyndman III was code 99233 (hospital e&m - subsequent), 938 times for 322 patients. In total Edward A Hyndman III billed 76,530 services in 50 codes, and Medicare paid $148K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 938 | 322 | $85.57 | $80K |
| 99223 Hospital E&M - Initial | Facility | 210 | 195 | $125.14 | $26K |
| 36415 Venipuncture Blood Collection | Office | 141 | 57 | $5.88 | $829 |
| 85025 Blood Count | Office | 112 | 49 | $7.55 | $845 |
| 99232 Hospital E&M - Subsequent | Facility | 108 | 72 | $57.25 | $6,183 |
| 99215 Office E&M - Established | Office | 102 | 60 | $124.32 | $13K |
| 85652 Clinical Chemistry | Office | 93 | 36 | $2.65 | $246 |
| 86140 Clinical Chemistry | Office | 90 | 35 | $5.08 | $457 |
| 80048 Clinical Chemistry | Office | 59 | 20 | $8.29 | $489 |
| 80053 Clinical Chemistry | Office | 44 | 31 | $9.93 | $437 |
| 99214 Office E&M - Established | Office | 40 | 33 | $83.34 | $3,334 |
By year: 2022 $131K for 4,049 services; 2023 $149K for 1,950 services; 2024 $148K for 76,530 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 141 | 57 | $5.88 | $829 |
| 85025 Blood Count | 112 | 49 | $7.55 | $845 |
| 85652 Clinical Chemistry | 93 | 36 | $2.65 | $246 |
| 86140 Clinical Chemistry | 90 | 35 | $5.08 | $457 |
| 80048 Clinical Chemistry | 59 | 20 | $8.29 | $489 |
| 80053 Clinical Chemistry | 44 | 31 | $9.93 | $437 |
Medicare prescription drug claims, 2024
In 2024, the drug Edward A Hyndman III prescribed most often to Medicare patients was Vancomycin Hcl, with 238 prescriptions and refills. In total Edward A Hyndman III wrote 2,528 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vancomycin Hcl Generic | 238 | 238 | 49 | $26K |
| Sodium Chloride 0.9 % Sodium Chloride | 220 | 220 | 40 | $3,306 |
| Cefepime Hcl Generic | 208 | 208 | 39 | $30K |
| Daptomycin Generic | 169 | 169 | 37 | $67K |
| Doxycycline Monohydrate Generic | 145 | 171 | 44 | $6,236 |
| Ceftriaxone Ceftriaxone Sodium | 135 | 135 | 32 | $8,917 |
| Cephalexin Generic | 105 | 126 | 26 | $2,989 |
| Ertapenem Ertapenem Sodium | 77 | 77 | 21 | $24K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 66 | 66 | 19 | $15K |
| Azithromycin Generic | 57 | 68 | Under 11 | $1,229 |
| Fluconazole Generic | 57 | 74 | 21 | $542 |
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 53 | 53 | Under 11 | $2,453 |
| Cefadroxil Generic | 52 | 54 | 13 | $4,440 |
| Dovato Dolutegravir Sodium/Lamivudine | 50 | 68 | Under 11 | $202K |
| Ciprofloxacin Hcl Generic | 49 | 49 | 18 | $1,560 |
Brand drugs: 553 claims; generic drugs: 1,975 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward A Hyndman III $922 ($922 in general payments such as food, travel and fees) from 9 companies. The largest payer was ViiV Healthcare Company with $381.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.